Skip to main navigation
  • News & Investors

    News & Investors

    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact
  • Contact Us
Celsion
  • TECHNOLOGY
    • LTSL
    • TheraPlas
    • TheraSilence
  • PRODUCTS
    • ThermoDox
    • GEN-1
  • PIPELINE
    • Clinical Studies
    • Pre-clinical Programs
  • DISEASES
  • PUBLICATIONS
  • ABOUT US
    • Leadership
    • Board of Directors
    • Corporate Governance
Select Page

SEC Filings

    Investor Relations

    • News & Investors
    • Press Releases
    • Financial Events
    • Scientific Presentations
    • Corporate Governance
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Stock Information
    • Analyst Coverage
    • Request Information
    • Investor FAQs
    • Investor Contact

SEC Filings

Filing date Form Description View
Feb 11, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-21-003307.pdf
0001493152-21-003307.xls
Feb 3, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-21-002531.pdf
0001493152-21-002531.xls
Feb 1, 2021 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0001493152-21-002216.pdf
0001493152-21-002216.xls
Jan 29, 2021 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001104659-21-009165.pdf
0001104659-21-009165.xls
Jan 29, 2021 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0001104659-21-009189.pdf
0001104659-21-009189.xls
Jan 29, 2021 SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
0001387131-21-001520.pdf
Jan 29, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001493152-21-002116.pdf
0001493152-21-002116.xls
Jan 25, 2021 SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
0001513162-21-000015.pdf
0001513162-21-000015.xls
Jan 25, 2021 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
0001493152-21-001756.pdf
0001493152-21-001756.xls
Jan 25, 2021 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
0001493152-21-001759.pdf
0001493152-21-001759.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • Downloads
    • RSS
    • Print
    • Search

    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

Home

Technology

Products

Pipeline

Disease

Publications

News & Investors

About Us

Careers

Privacy Policy

    ThermoDox is a registered trademark of Celsion Corporation.
    TheraPlas and TheraSilence are trademarks of Celsion Corporation.
    Avastin is a registered trademark of Genentech, Inc.
    Copyright © 2021 Celsion Corporation. All rights reserved.

    Share This
    • Twitter
    • Google+
    • Facebook
    • LinkedIn